Accelerating the tech-driven bioeconomy


The time is ripe for a global transition to a bio-based economy. Powered by the ever-evolving capacity to read, write, edit and increasingly functionalize deoxyribonucleic acid (DNA), the tech-enabled bioeconomy promises fundamental improvements in everyday life. Digital advances are also expanding the areas where biology can deliver impact, and generative biology is set to disrupt several industries. Yet, despite decades of investment and technological progress, as well as sanguine market projections, the global transition to a bio-based economy has yet to enter the commercial mainstream.